|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.65 CNY | -3.84% |
|
-5.79% | +4.07% |
| Capitalization | 22.45B 3.1B 2.95B 2.73B 2.43B 4.38B 263B 4.86B 34B 12.55B 108B 11.62B 11.37B 471B | P/E ratio 2024 * |
42.6x | P/E ratio 2025 * | 30.3x |
|---|---|---|---|---|---|
| Enterprise value | 24.3B 3.35B 3.19B 2.96B 2.63B 4.74B 284B 5.26B 36.8B 13.58B 117B 12.58B 12.31B 509B | EV / Sales 2024 * |
7.86x | EV / Sales 2025 * | 6.3x |
| Free-Float |
51.51% | Yield 2024 * |
0.51% | Yield 2025 * | 0.74% |
More valuation ratios
* Estimated data
More news
| 1 day | -3.84% | ||
| 1 week | -5.79% | ||
| Current month | -3.07% | ||
| 1 month | +9.53% | ||
| 3 months | +45.39% | ||
| 6 months | +45.35% | ||
| Current year | +4.07% |
1 week
53.35
58.18
1 month
45.7159.00
Current year
30.4359.00
1 year
30.4359.80
3 years
30.4383.39
5 years
30.43160.66
10 years
23.19160.66
| Director | Title | Age | Since |
|---|---|---|---|
Jia Tong
CEO | Chief Executive Officer | 47 | 02/03/2020 |
Lie Ming Ding
CEO | Chief Executive Officer | 61 | 22/08/2013 |
Jian Xun Fan
DFI | Director of Finance/CFO | 53 | 30/03/2017 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lie Ming Ding
CHM | Chairman | 61 | 22/08/2013 |
Jia Bing Wang
BRD | Director/Board Member | 61 | 05/09/2017 |
Jia Tong
BRD | Director/Board Member | 47 | 21/01/2021 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.36% | 1 M€ | -20.08% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -3.84% | -5.79% | -7.04% | -34.89% | 3.21B | ||
| +2.08% | +1.58% | +2.48% | -35.57% | 65.18B | ||
| -1.00% | +0.18% | +4.15% | -23.60% | 8.45B | ||
| -0.16% | +1.24% | +21.19% | +42.26% | 6.24B | ||
| +7.69% | 0.00% | +87.82% | +113.23% | 5.73B | ||
| +5.37% | -0.58% | +13.19% | +0.59% | 5.31B | ||
| -0.97% | +0.25% | +21.39% | +27.62% | 2.27B | ||
| +0.42% | -0.43% | +39.13% | +27.62% | 2.03B | ||
| +0.57% | -2.18% | -31.97% | +30.80% | 2.01B | ||
| -.--% | -.--% | - | - | 1.64B | ||
| Average | +1.02% | -0.21% | +16.71% | +16.45% | 10.21B | |
| Weighted average by Cap. | +1.87% | -0.06% | +9.39% | -15.27% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 3.09B 426M 406M 376M 334M 604M 36.18B 669M 4.68B 1.73B 14.85B 1.6B 1.57B 64.82B | 3.79B 522M 497M 461M 410M 740M 44.31B 820M 5.74B 2.12B 18.2B 1.96B 1.92B 79.41B |
| Net income | 528M 72.74M 69.23M 64.16M 57.07M 103M 6.17B 114M 799M 295M 2.53B 273M 267M 11.06B | 709M 97.74M 93.03M 86.21M 76.68M 138M 8.29B 153M 1.07B 396M 3.41B 367M 359M 14.86B |
| Net Debt | 1.85B 255M 242M 225M 200M 361M 21.61B 400M 2.8B 1.03B 8.87B 956M 935M 38.73B | 1.42B 196M 187M 173M 154M 278M 16.66B 308M 2.16B 796M 6.84B 737M 721M 29.85B |
More financial data
* Estimated data
Employees
1,961
Sector
Pharmaceuticals
Calendar
22/04/2025
- Q1 2025 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/12/24 | 53.65 ¥ | -3.84% | 12,817,100 |
| 09/12/24 | 55.79 ¥ | -3.01% | 7,653,354 |
| 06/12/24 | 57.52 ¥ | +3.83% | 8,668,726 |
| 05/12/24 | 55.40 ¥ | -0.11% | 5,928,162 |
| 04/12/24 | 55.46 ¥ | -3.41% | 11,501,560 |
End-of-day quote Shenzhen S.E., December 09, 2024
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
53.65CNY
Average target price
56.83CNY
Spread / Average Target
+5.92%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300558 Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition